Get startedLog in
    Picture of Clinical Laserthermia Systems AB logo

    CLS B — Clinical Laserthermia Systems AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    HealthcareHighly SpeculativeMicro CapSucker Stock
    All News

    Brief: CLS Q2 Operating Loss Widens To SEK 13.6 Mln

    Picture of Clinical Laserthermia Systems AB logoClinical Laserthermia Systems AB
    20/07/2026 07:18
    BRIEF-CLS Q2 Operating Loss Widens To SEK 13.6 Mln
    July 20 (Reuters) - Clinical Laserthermia Systems AB (publ) CLSRb.ST:
    • SAID ON FRIDAY Q2 NET SALES AMOUNTED TO SEK 7.7 MILLION, VERSUS SEK 9.4 MILLION YEAR AGO
    • Q2 OPERATING LOSS SEK 13.6 MILLION VERSUS LOSS SEK 2.9 MILLION YEAR AGO
    • OUTLOOK 2026: STILL EXPECTS FY 2026 REVENUE TO SHOW STRONG DOUBLE-DIGIT GROWTH, COMPARED TO 2025, WITH PERFORMANCE WEIGHTED TOWARDS H2 2026
    • EXPECTS TO REQUIRE ADDITIONAL CAPITAL TO EXECUTE ITS BUSINESS PLAN THROUGH EXPECTED POSITIVE CASH FLOW IN Q1 2028
         

    Source text: ID:nWkr9Tsfm8
    Further company coverage: [CLSRb.ST] 

    (Gdansk Newsroom)
    ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))

    Recent news on Clinical Laserthermia Systems AB

    See all news